The composition of the gut microbiota is significantly altered in individuals suffering from Long COVID, a condition referred to as gut dysbiosis. Studies have demonstrated a marked depletion of beneficial bacterial species such as Faecalibacterium prausnitzii, Bifidobacterium, and Akkermansia muciniphila, all of which play crucial roles in maintaining gut integrity and modulating immune responses. Concurrently, there is an increase in pathogenic bacteria, including Enterobacteriaceae, Clostridium difficile, and Escherichia coli, which contribute to intestinal inflammation, increased gut permeability, and systemic immune activation. The loss of beneficial bacteria also leads to a reduction in the production of short-chain fatty acids (SCFAs) such as butyrate, which are essential for maintaining the intestinal barrier and regulating neuroimmune communication. The persistence of gut dysbiosis in Long COVID patients correlates with the severity of neurological and GI symptoms, suggesting a direct link between microbial imbalance and prolonged post-viral illness^[1,2].

The vagus nerve plays a critical role in the gut-brain axis by facilitating bidirectional communication between the enteric nervous system and the brain. Long COVID is associated with vagus nerve dysfunction, which may contribute to persistent autonomic dysregulation, fatigue, and cognitive impairment. Elevated levels of pro-inflammatory cytokines such as IL-6, TNF-α, and IFN-γ have been detected in Long COVID patients, contributing to chronic neuroinflammation and microglial activation. This inflammatory state impairs vagal tone and alters neurotransmitter synthesis, particularly affecting serotonin, dopamine, and gamma-aminobutyric acid (GABA) levels, leading to symptoms such as brain fog, anxiety, and mood disorders. Vagus nerve dysfunction also disrupts normal gut motility, contributing to gastrointestinal symptoms such as diarrhea, constipation, and irritable bowel syndrome (IBS)-like conditions commonly reported in Long COVID patients^[3,4].

Gastrointestinal disturbances are among the most common complaints in Long COVID patients. Symptoms such as chronic diarrhea, bloating, nausea, and abdominal pain have been observed in individuals months after the resolution of acute infection. These symptoms may be driven by post-viral enteric nervous system dysfunction and gut dysbiosis. Increased intestinal permeability, often referred to as “leaky gut,” allows bacterial endotoxins such as lipopolysaccharides (LPS) to enter the bloodstream, triggering a systemic inflammatory response that further exacerbates neurological and gastrointestinal symptoms. The link between post-infectious IBS and Long COVID suggests that SARS-CoV-2 infection can induce long-term alterations in gut function similar to those seen after other viral and bacterial infections^[5].

One of the most debilitating aspects of Long COVID is cognitive impairment, often described as “brain fog,” which manifests as memory difficulties, reduced concentration, and mental fatigue. Recent studies suggest that gut microbiota imbalance contributes to neuroinflammation, disrupting normal cognitive processing. The depletion of SCFA-producing bacteria affects microglial regulation, leading to sustained neuroinflammation and impaired synaptic plasticity. Evidence also suggests that Long COVID may accelerate neurodegenerative processes, increasing the risk of conditions such as Alzheimer’s and Parkinson’s disease. Chronic neuroinflammation, oxidative stress, and mitochondrial dysfunction have been implicated in the progression of these disorders, making the gut-brain connection a potential therapeutic target for reducing neurodegenerative risk in Long COVID patients^[6].

Restoring gut microbiota balance is a promising strategy for mitigating Long COVID symptoms. Probiotic supplementation with Lactobacillus and Bifidobacterium strains has been shown to improve gut barrier integrity, reduce systemic inflammation, and enhance serotonin and GABA production, thereby improving mood and cognitive function. Prebiotics, such as inulin and resistant starches, promote the growth of beneficial bacteria, while postbiotics, particularly butyrate supplements, provide anti-inflammatory benefits^[7].

Fecal microbiota transplantation (FMT) has emerged as a potential treatment for severe gut dysbiosis and persistent GI symptoms in Long COVID patients. Early clinical trials suggest that FMT can restore microbial diversity, reduce gut permeability, and alleviate neuroinflammation, making it a promising intervention for gut-brain axis dysfunction^[8]. Other gut-directed therapies, including phytochemicals such as curcumin and resveratrol, have shown neuroprotective and anti-inflammatory properties that could benefit Long COVID patients.

Given the role of the vagus nerve in modulating the gut-brain axis, non-invasive vagus nerve stimulation (VNS) has been proposed as a novel therapeutic approach for Long COVID. Studies indicate that VNS can reduce neuroinflammation, improve autonomic regulation, and enhance gut motility, making it a viable option for patients suffering from both neurological and gastrointestinal symptoms^[9].